Universal Biosensors Inc
Company Profile
Business description
Universal Biosensors Inc is a biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food, and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride, and Xprecia Prime, which are medical devices; Sentia non-medical wine testing products, and Petrackr, which is a blood glucose test used in cats and dogs. It has one reportable segment: a specialist biosensors company. Geographically, the company generates the majority of its revenue from Australia and rest from Americas, Europe and other markets.
Contact
1 Corporate Avenue
RowvilleVIC3178
AUST: +61 392139000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
76
Stocks News & Analysis
stocks
ASX retail share remains cheap despite weaker earnings
stocks
AI isn’t an economic moat killer, but it will disrupt industries
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,726.50 | 32.00 | -0.37% |
| CAC 40 | 7,801.77 | 44.78 | -0.57% |
| DAX 40 | 22,673.66 | 283.42 | -1.23% |
| Dow JONES (US) | 46,429.49 | 305.43 | 0.66% |
| FTSE 100 | 10,015.78 | 91.06 | -0.90% |
| HKSE | 24,856.43 | 479.52 | -1.89% |
| NASDAQ | 21,929.82 | 167.93 | 0.77% |
| Nikkei 225 | 53,603.65 | 145.97 | -0.27% |
| NZX 50 Index | 12,976.99 | 47.69 | 0.37% |
| S&P 500 | 6,591.90 | 35.53 | 0.54% |
| S&P/ASX 200 | 8,525.70 | 21.30 | -0.25% |
| SSE Composite Index | 3,889.08 | 42.75 | -1.09% |